Related Experiment Video
Updated: Apr 3, 2026

In Vitro Stimulation and Visualization of Extracellular Trap Release in Differentiated Human Monocyte-derived Macrophages
Published on: November 1, 2019
[TNF-α induces the release of high mobility group protein B1 through p38 mitogen-activated protein kinase pathway in
Ruike Wang1, Qinqin Zhang1, Shenghui Yang1
1Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Objective:
To determine the effect of p38 MAPK inhibitor (SB203580) on TNF-α -induced high mobility group protein B1 (HMGB1) expression in microglial cells.
Methods:
Microglial cells were treated with TNF-α (25 ng/mL, TNF-α group), TNF-α plus SB203580 (10 μmol/L, TNF-α+SB203580 group), SB203580 (SB203580 group) or serum-free medium (control group). After 16 h of incubation, the protein levels of p-p38 MAPK and HMGB1, and mRNA levels of HMGB1 were examined by ELISA, Western Blot and RT-PCR, respectively.
Results:
There was a significant increase in p-p38 MAPK and HMGB1 levels in TNF-α-treated microglia cells (P<0.01). The TNF-α-induced HMGB1 protein and mRNA expression was suppressed by SB203580.
Conclusion:
TNF-α up-regulates HMGB1 expression in microglial cells through activation of the p38 MAPK pathway.
Insights
Tumor necrosis factor-alpha (TNF-α) increases high mobility group protein B1 (HMGB1) in microglial cells via p38 MAPK. A p38 MAPK inhibitor, SB203580, suppressed this TNF-α-induced HMGB1 expression.
Area of Science:
- Neuroinflammation
- Cellular signaling pathways
- Molecular biology
Background:
- Microglial cells are key immune cells in the central nervous system.
- High mobility group protein B1 (HMGB1) is implicated in inflammatory responses.
- Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine.
Purpose of the Study:
- To investigate the role of the p38 mitogen-activated protein kinase (MAPK) pathway in TNF-α-induced HMGB1 expression in microglial cells.
- To evaluate the effect of the p38 MAPK inhibitor SB203580 on HMGB1 expression.
Main Methods:
- Microglial cells were treated with TNF-α, SB203580, or both.
- Protein levels of phosphorylated p38 MAPK (p-p38 MAPK) and HMGB1 were measured using ELISA and Western Blot.
- HMGB1 mRNA levels were assessed via RT-PCR.
Main Results:
- TNF-α significantly increased p-p38 MAPK and HMGB1 protein and mRNA levels in microglial cells.
- Treatment with SB203580 effectively suppressed the TNF-α-induced upregulation of HMGB1 at both protein and mRNA levels.
Conclusions:
- The p38 MAPK pathway is activated by TNF-α in microglial cells.
- TNF-α upregulates HMGB1 expression in microglial cells through the activation of the p38 MAPK pathway.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
MAPK Signaling Cascades
NF-kB-dependent Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

